NeuroOne Medical Technologies Corporation (NMTC)
USD 0.86
(0.0%)
USD 0.86
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 456.51 Thousand USD | 744.85% |
| 2022 | -70.79 Thousand USD | 27.58% |
| 2021 | -97.74 Thousand USD | -254.87% |
| 2020 | 63.11 Thousand USD | 328.94% |
| 2019 | -27.56 Thousand USD | -27.24% |
| 2018 | -21.66 Thousand USD | -22.88% |
| 2017 | -17.63 Thousand USD | -127.82% |
| 2016 | -7740.00 USD | -1143.13% |
| 2015 | 742.00 USD | -4.01% |
| 2014 | 773.00 USD | -38.11% |
| 2013 | 1249.00 USD | 35.61% |
| 2012 | 921.00 USD | -71.75% |
| 2011 | 3260.00 USD | 179.35% |
| 2010 | 1167.00 USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 390.41 Thousand USD | 46.6% |
| 2024 Q3 | 281.87 Thousand USD | -27.8% |
| 2024 Q1 | 266.31 Thousand USD | 37.52% |
| 2023 Q2 | 31.5 Thousand USD | 355.98% |
| 2023 FY | 456.51 Thousand USD | 744.85% |
| 2023 Q4 | 193.65 Thousand USD | -20.52% |
| 2023 Q1 | -12.3 Thousand USD | 18.29% |
| 2023 Q3 | 243.66 Thousand USD | 673.47% |
| 2022 Q3 | -6413.00 USD | 82.3% |
| 2022 FY | -70.79 Thousand USD | 27.58% |
| 2022 Q4 | -15.06 Thousand USD | -134.87% |
| 2022 Q2 | -36.22 Thousand USD | -176.6% |
| 2022 Q1 | -13.09 Thousand USD | 23.55% |
| 2021 Q4 | -17.13 Thousand USD | 21.56% |
| 2021 FY | -97.74 Thousand USD | -254.87% |
| 2021 Q1 | -37.65 Thousand USD | -102.78% |
| 2021 Q2 | -21.12 Thousand USD | 43.91% |
| 2021 Q3 | -21.83 Thousand USD | -3.39% |
| 2020 Q2 | -342.1 Thousand USD | 31.83% |
| 2020 Q1 | -501.81 Thousand USD | 67.18% |
| 2020 Q3 | -447.15 Thousand USD | -30.71% |
| 2020 FY | 63.11 Thousand USD | 328.94% |
| 2020 Q4 | 1.35 Million USD | 402.85% |
| 2019 Q1 | - USD | 0.0% |
| 2019 Q4 | -1.52 Million USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2019 FY | -27.56 Thousand USD | -27.24% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 FY | -21.66 Thousand USD | -22.88% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2017 FY | -17.63 Thousand USD | -127.82% |
| 2017 Q4 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2016 Q1 | 281.00 USD | 485.42% |
| 2016 Q2 | 102.00 USD | -63.7% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q3 | - USD | -100.0% |
| 2016 FY | -7740.00 USD | -1143.13% |
| 2015 FY | 742.00 USD | -4.01% |
| 2015 Q4 | 48.00 USD | -84.0% |
| 2015 Q3 | 300.00 USD | 165.49% |
| 2015 Q2 | 113.00 USD | -31.93% |
| 2015 Q1 | 166.00 USD | 19.42% |
| 2014 Q3 | 303.00 USD | 83.64% |
| 2014 Q2 | 165.00 USD | 17.86% |
| 2014 Q1 | 140.00 USD | -44.44% |
| 2014 FY | 773.00 USD | -38.11% |
| 2014 Q4 | 139.00 USD | -54.13% |
| 2013 Q2 | 406.00 USD | 12.78% |
| 2013 Q4 | 252.00 USD | -44.12% |
| 2013 Q3 | 451.00 USD | 11.08% |
| 2013 FY | 1249.00 USD | 35.61% |
| 2013 Q1 | 360.00 USD | 1465.22% |
| 2012 Q1 | -1841.00 USD | -326.72% |
| 2012 Q3 | 391.00 USD | 165.99% |
| 2012 Q4 | 23.00 USD | -94.12% |
| 2012 FY | 921.00 USD | -71.75% |
| 2012 Q2 | 147.00 USD | 107.98% |
| 2011 Q3 | 1218.00 USD | -60.34% |
| 2011 Q4 | 812.00 USD | -33.33% |
| 2011 Q1 | - USD | -100.0% |
| 2011 Q2 | 3071.00 USD | 0.0% |
| 2011 FY | 3260.00 USD | 179.35% |
| 2010 Q3 | 398.00 USD | 0.0% |
| 2010 FY | 1167.00 USD | 0.0% |
| 2010 Q4 | 273.00 USD | -31.41% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acutus Medical, Inc. | -3.13 Million USD | 114.553% |
| Cerus Corporation | 86.4 Million USD | 99.472% |
| OrthoPediatrics Corp. | 111.25 Million USD | 99.59% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | 38.269% |
| Talis Biomedical Corporation | 371 Thousand USD | -23.05% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | 94.481% |
| Inogen, Inc. | 126.69 Million USD | 99.64% |
| Spectral AI, Inc. | 7.88 Million USD | 94.207% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 106.925% |
| CVRx, Inc. | 33.03 Million USD | 98.618% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -648.389% |
| Orthofix Medical Inc. | 486.27 Million USD | 99.906% |
| Venus Concept Inc. | 52.16 Million USD | 99.125% |
| Accelerate Diagnostics, Inc. | 2.55 Million USD | 82.097% |
| Bioventus Inc. | 328.19 Million USD | 99.861% |
| BrainsWay Ltd. | 23.09 Million USD | 98.023% |
| Envoy Medical, Inc. | -473 Thousand USD | 196.515% |
| electroCore, Inc. | 13.22 Million USD | 96.548% |
| IceCure Medical Ltd | 1.3 Million USD | 64.883% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 107.546% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 1064.418% |
| MaxCyte, Inc. | 36.54 Million USD | 98.751% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -436.7% |
| PAVmed Inc | -3.96 Million USD | 111.505% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 108.323% |
| RxSight, Inc. | 53.76 Million USD | 99.151% |
| Sight Sciences, Inc. | 69.17 Million USD | 99.34% |
| SI-BONE, Inc. | 109.42 Million USD | 99.583% |
| TELA Bio, Inc. | 40.11 Million USD | 98.862% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | 97.13% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 99.7% |
| LivaNova PLC | 771.25 Million USD | 99.941% |
| 908 Devices Inc. | 25.32 Million USD | 98.197% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 99.853% |
| Nemaura Medical Inc. | -1.47 Million USD | 130.921% |
| NeuroPace, Inc. | 48.12 Million USD | 99.051% |
| LENSAR, Inc. | 21.1 Million USD | 97.837% |
| Apyx Medical Corporation | 14.12 Million USD | 96.767% |
| Cutera, Inc. | 41.49 Million USD | 98.9% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | 97.527% |
| BioSig Technologies, Inc. | 18 Thousand USD | -2436.206% |
| Anika Therapeutics, Inc. | 103.08 Million USD | 99.557% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | 96.647% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 99.949% |
| Axonics, Inc. | 274.55 Million USD | 99.834% |
| Outset Medical, Inc. | 29 Million USD | 98.426% |
| IRIDEX Corporation | 21.8 Million USD | 97.907% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | 99.357% |
| IRadimed Corporation | 50.15 Million USD | 99.09% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -59.065% |
| INVO Bioscience, Inc. | 1.08 Million USD | 57.969% |
| Telesis Bio, Inc. | 16.95 Million USD | 97.307% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 99.595% |
| Varex Imaging Corporation | 256.9 Million USD | 99.822% |
| Quipt Home Medical Corp. | 163.84 Million USD | 99.721% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 212.443% |
| Pulmonx Corporation | 50.75 Million USD | 99.1% |
| Dynatronics Corporation | 7.63 Million USD | 94.021% |
| Modular Medical, Inc. | -768 Thousand USD | 159.442% |
| ReShape Lifesciences Inc. | 5.54 Million USD | 91.772% |
| Semler Scientific, Inc. | 61.2 Million USD | 99.254% |
| InMode Ltd. | 411.34 Million USD | 99.889% |
| Bruker Corporation | 1.51 Billion USD | 99.97% |
| Cytosorbents Corporation | 22.39 Million USD | 97.961% |
| DexCom, Inc. | 2.28 Billion USD | 99.98% |
| Align Technology, Inc. | 2.71 Billion USD | 99.983% |
| Viveve Medical, Inc. | 620 Thousand USD | 26.368% |
| ZimVie Inc. | 290.38 Million USD | 99.843% |
| Movano Inc. | -158 Thousand USD | 388.935% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 99.583% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -436.7% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 99.876% |
| Profound Medical Corp. | 4.51 Million USD | 89.887% |
| Insulet Corporation | 1.15 Billion USD | 99.961% |
| enVVeno Medical Corporation | -546 Thousand USD | 183.611% |
| Surmodics, Inc. | 93.05 Million USD | 99.509% |
| iCAD, Inc. | 14.53 Million USD | 96.859% |
| Nuwellis, Inc. | 4.98 Million USD | 90.839% |
| Biotricity, Inc. | 8.35 Million USD | 94.537% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 99.862% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 227.143% |
| InspireMD, Inc. | 1.8 Million USD | 74.736% |
| PAVmed Inc. | -3.96 Million USD | 111.505% |
| BIOLASE, Inc. | 16.72 Million USD | 97.27% |
| Beyond Air, Inc. | -1.3 Million USD | 134.929% |
| FONAR Corporation | 45.14 Million USD | 98.989% |
| AxoGen, Inc. | 127.87 Million USD | 99.643% |
| Vivani Medical, Inc. | -357 Thousand USD | 227.876% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 99.766% |
| Inari Medical, Inc. | 434.56 Million USD | 99.895% |
| UFP Technologies, Inc. | 112.22 Million USD | 99.593% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -3546.593% |
| Tenon Medical, Inc. | 1.24 Million USD | 63.214% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 663.601% |
| Co-Diagnostics, Inc. | 2.62 Million USD | 82.623% |
| AdaptHealth Corp. | 479.56 Million USD | 99.905% |
| Sintx Technologies, Inc. | 1.84 Million USD | 75.23% |
| NanoVibronix, Inc. | 1.53 Million USD | 70.298% |
| Quanterix Corporation | 70.64 Million USD | 99.354% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 212.443% |
| Sensus Healthcare, Inc. | 14.06 Million USD | 96.753% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | 99.135% |
| TransMedics Group, Inc. | 154.09 Million USD | 99.704% |
| ReWalk Robotics Ltd. | 4.45 Million USD | 89.748% |
| NeuroMetrix, Inc. | 3.94 Million USD | 88.435% |
| Hyperfine, Inc. | 4.75 Million USD | 90.403% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 99.573% |
| Biomerica, Inc. | 611 Thousand USD | 25.284% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | 98.905% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 158.456% |
| Silk Road Medical, Inc | 127.08 Million USD | 99.641% |